Flag of the European Union EU Clinical Trials Register Help

Clinical trials for Olopatadine

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

    • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).

    The EU Clinical Trials Register currently displays   44334   clinical trials with a EudraCT protocol, of which   7366   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    11 result(s) found for: Olopatadine. Displaying page 1 of 1.
    EudraCT Number: 2016-004317-27 Sponsor Protocol Number: EXC458-C001/C-12-010 Start Date*: 2017-07-03
    Sponsor Name:Alcon China Ophthalmic
    Full Title: A Comparative Study of Olopatadine Hydrochloride Ophthalmic Solution 0.2% QD vs Olopatadine Hydrochloride Ophthalmic Solution 0.1% BID in the Treatment of Allergic Conjunctivitis in Chinese Subjects
    Medical condition: Allergic conjunctivitis
    Disease: Version SOC Term Classification Code Term Level
    20.0 100000014962 10001709 Allergic conjunctivitis LLT
    Population Age: Children, Adolescents, Under 18, Adults, Elderly Gender: Male, Female
    Trial protocol: Outside EU/EEA
    Trial results: View results
    EudraCT Number: 2017-002728-26 Sponsor Protocol Number: C-12-028 Start Date*: 2017-11-07
    Sponsor Name:Alcon Research
    Full Title: A Multicenter, Randomized, Double-Masked, Vehicle-Controlled, Parallel-Group Study Evaluating the Safety of olopatadine hydrochloride (AL-4943A) Ophthalmic Solution 0.77% Administered Once Daily
    Medical condition: asymptomatic allergic conjunctivitis
    Disease: Version SOC Term Classification Code Term Level
    20.0 10015919 - Eye disorders 10010744 Conjunctivitis allergic PT
    Population Age: Children, Adolescents, Under 18, Adults, Elderly Gender: Male, Female
    Trial protocol: Outside EU/EEA
    Trial results: View results
    EudraCT Number: 2017-003846-26 Sponsor Protocol Number: C-05-69 Start Date*: 2017-11-19
    Sponsor Name:Alcon Research Ltd
    Full Title: Safety Study of Olopatadine Nasal Spray
    Medical condition: perennial allergic rhinitis
    Disease: Version SOC Term Classification Code Term Level
    20.0 100000004855 10034382 Perennial allergic rhinitis LLT
    Population Age: Adolescents, Under 18, Adults, Elderly Gender: Male, Female
    Trial protocol: Outside EU/EEA
    Trial results: View results
    EudraCT Number: 2017-003953-41 Sponsor Protocol Number: C-09-50 Start Date*: 2017-11-22
    Sponsor Name:Alcon Research Ltd
    Full Title: An Open-label, Long-term Study, with AL-4943A Ophthalmic Solution, 0.2% in Patients with Allergic Conjunctivitis
    Medical condition: Allergic conjunctivitis
    Disease: Version SOC Term Classification Code Term Level
    20.0 100000004853 10001709 Allergic conjunctivitis LLT
    Population Age: Adolescents, Under 18, Adults Gender: Male, Female
    Trial protocol: Outside EU/EEA
    Trial results: View results
    EudraCT Number: 2017-003970-16 Sponsor Protocol Number: C-07-02 Start Date*: 2017-11-22
    Sponsor Name:Alcon Research Ltd
    Full Title: Safety and Pharmacokinetics of PATANASE in Paediatric Patients 2 to < 6 Years of Age with a history of allergic rhinitis
    Medical condition: Allergic rhinitis
    Disease: Version SOC Term Classification Code Term Level
    20.0 100000004855 10001723 Allergic rhinitis LLT
    Population Age: Children, Under 18 Gender: Male, Female
    Trial protocol: Outside EU/EEA
    Trial results: View results
    EudraCT Number: 2017-003856-22 Sponsor Protocol Number: C-07-01 Start Date*: 2017-11-07
    Sponsor Name:Alcon Research Ltd
    Full Title: Safety and Efficacy of Olopatadine Hydrochloride Nasal Spray in 6-11 Year old Patients.
    Medical condition: Seasonal Allergic Rhinitis
    Disease: Version SOC Term Classification Code Term Level
    20.0 100000004870 10039776 Seasonal allergic rhinitis LLT
    Population Age: Children, Under 18 Gender: Male, Female
    Trial protocol: Outside EU/EEA
    Trial results: View results
    EudraCT Number: 2017-003841-39 Sponsor Protocol Number: JPN-P-2010-1 Start Date*: 2017-11-07
    Sponsor Name:Alcon Research
    Full Title: Clinical Evaluation of 0.1% Olopatadine Hydrochloride Ophthalmic Solution in Paediatric Patients
    Medical condition: allergic conjunctivitis
    Disease: Version SOC Term Classification Code Term Level
    20.0 10015919 - Eye disorders 10010744 Conjunctivitis allergic PT
    Population Age: Children, Adolescents, Under 18 Gender: Male, Female
    Trial protocol: Outside EU/EEA
    Trial results: View results
    EudraCT Number: 2017-002726-20 Sponsor Protocol Number: C-08-32 Start Date*: 2017-11-07
    Sponsor Name:Alcon Research Ltd
    Full Title: Safety of PATANASE® Nasal Spray in Patients With Perennial Allergic Rhinitis
    Medical condition: Perennial Allergic Rhinitis
    Disease: Version SOC Term Classification Code Term Level
    20.0 100000004855 10034382 Perennial allergic rhinitis LLT
    Population Age: Adolescents, Under 18, Adults, Elderly Gender: Male, Female
    Trial protocol: Outside EU/EEA
    Trial results: View results
    EudraCT Number: 2005-004768-22 Sponsor Protocol Number: C-05-30 Start Date*: 2006-06-12
    Sponsor Name:ALCON ITALIA
    Full Title: Clinical study of the mast-cell stabilizing effects of the Olopatadine using the Conjunctival Allergen Challeenge model
    Medical condition: subjects with a clinical history of seasonal allergic conjunctivitis, but asymptomatic and free of any topical or systemic medication at baseline
    Disease: Version SOC Term Classification Code Term Level
    6.1 10010744 PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: IT (Completed)
    Trial results: View results
    EudraCT Number: 2015-004821-15 Sponsor Protocol Number: TT-04 Start Date*: 2016-03-18
    Sponsor Name:ALK Abello A/S
    Full Title: Efficacy and safety of the SQ tree SLIT-tablet in subjects with moderate to severe allergic rhinitis and/or conjunctivitis induced by pollen from the birch group
    Medical condition: Allergic Rhinoconjunctivitis induced by birch pollen
    Disease: Version SOC Term Classification Code Term Level
    19.0 100000004870 10066093 Birch pollen allergy LLT
    Population Age: Adolescents, Under 18, Adults Gender: Male, Female
    Trial protocol: DK (Completed) SE (Completed) CZ (Completed) FI (Completed) DE (Completed) PL (Completed) FR (Completed)
    Trial results: View results
    EudraCT Number: 2007-000059-33 Sponsor Protocol Number: HMC-OFT-07-01 Start Date*: 2007-06-04
    Sponsor Name:Dra. Carmen Ispa Callén
    Full Title: "Eficacia y seguridad en el tratamiento de conjuntivitis por adenovirus tratados con olopatadina (Opatanol®) y lágrimas artificiales (Acuolens®)) vs pranoprofeno (Oftalar®) y lágrimas artificiales ...
    Medical condition: Conjuntivitis vírica por Adenovirus Adenoviral conjuntivitis
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: ES (Ongoing)
    Trial results: (No results available)
    Download Options:
    Number of Trials to download:
    Download Content:
    Download Format:
    Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
    Query did not match any studies.
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Wed May 07 14:28:22 CEST 2025 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA